Infrequent somatic alteration of p16/MTS1 in human primary superficial bladder cancers

Cancer Letters

Volumn 103, Issue 2, 1996, Pages 227-231

  Okajima, Eijiro ^a   Fukuda, Tomokazu ^a   Okita, Shyunji ^a   Tsutsumi, Masahiro ^a   Hirao, Yoshihiko ^a   Okajima, Eigoro ^a   Konishi, Yoichi ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

p16 MTS1; Superficial bladder cancer

Indexed keywords

CYCLIN DEPENDENT KINASE;

ARTICLE; BLADDER CANCER; BLADDER CARCINOGENESIS; CHROMOSOME 9P; CLINICAL ARTICLE; ENZYME REGULATION; GENE DELETION; HUMAN; HUMAN TISSUE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SINGLE STRAND CONFORMATION POLYMORPHISM; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0029873201     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/0304-3835(96)04225-5     Document Type: Article

References (16)

1. Fountain, J.W., Karayiorgou, M., Ernstoff, M.S., Kirkwood, J.M., Vlock, D.R., Titus-Ernstoff, L., Bouchard, B., Vijayasaradhi, S., Houghton, A.N., Lahti, J., Kidd, V.J., Housman, D.E. and Dracopoli, N.C. (1992) Homozygous deletion within human chromosome band 9p21 in melanoma. Proc. Natl. Acad. Sci. USA, 89, 10557-10561.
2. Diaz, M.O., Rubin, C.M., Harden, A., Ziemin, S., Larson, R.A., Le Beau, M.M. and Rowley, J.D. (1990) Deletion of interferon genes in acute lymphoblastic leukemia. N. Engl. J. Med., 322, 77-82.
3. Olopade, O.I., Jenkins, R.B., Ransom, D.T., Malik, K., Pomykala, H., Nobori, T., Cowan, J.M., Rowley, J.D. and Diaz, M.O. (1992) Molecular analysis of the short arm of the chromosome 9 in human gliomas. Cancer Res., 52, 2523-2529.
4. Olopade, O.I., Buchhagen, D.L., Malik, K., Sheman, J., Nobori, T., Bader, S., Nau, M.M., Gazdar, A.F., Minna, J.D. and Diaz, M.O. (1993) Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancer. Cancer Res., 53, 2410-2415.
5. Ruppert, J.M., Tokino, K. and Sidransky, D. (1993) Evidence of two bladder cancer suppressor loci on chromosome 9. Cancer Res., 53, 5093-5095.
6. Miyao, N., Tasi, Y.C., Lerner, S.P., Olumi, A.F., Spruck, III, C.H., Gnzalez-Zulueta, M., Nichols, P.W., Skinner, D.G. and Jones, P.A. (1993) Role of chromosome 9 in human bladder cancer. Cancer Res., 53, 4066-4070.
7. Cairns, P., Shaw, M.E. and Knowles, M.A. (1993) Preliminary mapping of the deleted region of chromosome 9 in bladder cancer. Cancer Res., 53, 1230-1232.
8. Kamb, A., Gruis, K.A., Weber-Feldhaus, J., Liu, Q., Harshman, K., Tavitigan, S.V., Stockert, E., Day, III, R.S., Johnson, B.E. and Skolnick, M.H. (1994) A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264, 436-440.
9. Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K. and Carson, D.A. (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368, 753-756.
10. Caldas, C., Hahn, S.A., da Costa, L.T., Redston, M.S., Schutte, M., Seymour, A.B., Weinstein, C.L., Hruban, R.H., Yeo, C.J. and Kern, S.E. (1994) Frequent somatic alterations and homozygous deletions of the p16(MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8, 27-32.
11. Zhou, X., Tarmin, L., Yin, J., Jiang, H.Y., Suzuki, H., Rhyu, M.G., Abraham, J.M. and Meltzer, S.J. (1994) The MTS1 gene is frequently mutated in primary human esophageal tumors. Oncogene, 9, 3737-3741.
12. Kai, M., Arakawa, H., Sugimoto, Y., Ogawa, M. and Nakamura, Y. (1995) Infrequent somatic mutation of the MTS1 in primary bladder carcinomas. Jpn. J. Cancer Res., 86, 249-251.
13. Wright, D.K. and Manos, M.M. (1990) Sample preparation from paraffin-embedded tissues. In: PCR Protocols, pp. 153-158. Editors: M.A. Innis, D.H. Gelfand, J.J. Sninsky and T.J. White. Academic Press, San Diego, CA.
14. Fujimoto, K., Ymada, Y., Okajima, E., Kakizoe, T., Sasaki, H. and Sugimura, T. (1992) Frequent association of p53 gene mutation in invasive bladder cancer. Cancer Res., 52, 1393-1398.
15. Ohashi, K., Tsutsumi, M., Nakjima, Y., Noguchi, O., Okita, S., Kitada, H., Tsujiuchi, T., Kobayashi, E., Nakano, H. and Konishi, Y. (1994) High rates of Ki-ras point mutation in both intra- and extra-hepatic cholangiocarcinoma. Jpn. J. Clin. Oncol., 24, 305-310.
16. Renade, K, Hussussian, C.J., Sikorski, R.S., Varmus, H.E., Goldstein, A.M., Tucker, M.A., Serrano, M., Hannon, G.J., Beach, D. and Dracopoli, N.C. (1995) Mutations associated with familial melanoma impair p16INK4 function. Nat. Genet., 10, 114-116.